Completion of Nuvista Pharma acquisition
Beximco Pharmaceuticals announced the company has completed the acquisition of a majority stake in Nuvista Pharma
Beximco Pharmaceuticals is manufacturer of generic pharmaceutical products and active pharmaceutical ingredients.
For the accquistion a total of 10,013,474 ordinary shares have been acquired from seven individual shareholders having an aggregate holding of 85.22% of the paid up capital of Nuvista.
Immediately after the acquisition, the board of Nuvista was reconstituted. The new five member board consists of four nominees from Beximco Pharma and one nominee representing the government shareholding in Nuvista.